External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia
Abstract
Share and Cite
Wang, S.; Yin, Q.; Yang, M.; Cheng, Z.; Xie, F. External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia. Pharmaceutics 2023, 15, 569. https://doi.org/10.3390/pharmaceutics15020569
Wang S, Yin Q, Yang M, Cheng Z, Xie F. External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia. Pharmaceutics. 2023; 15(2):569. https://doi.org/10.3390/pharmaceutics15020569
Chicago/Turabian StyleWang, Shengfeng, Qiufen Yin, Minghua Yang, Zeneng Cheng, and Feifan Xie. 2023. "External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia" Pharmaceutics 15, no. 2: 569. https://doi.org/10.3390/pharmaceutics15020569
APA StyleWang, S., Yin, Q., Yang, M., Cheng, Z., & Xie, F. (2023). External Evaluation of Population Pharmacokinetic Models of Methotrexate for Model-Informed Precision Dosing in Pediatric Patients with Acute Lymphoid Leukemia. Pharmaceutics, 15(2), 569. https://doi.org/10.3390/pharmaceutics15020569

